Discrimination analysis of breast calcifications using x‐ray dark‐field radiography
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Medical Physics 47.4 (2020): S. 1813-1826.
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2020
- Urheber
-
Rauch, Thomas
Rieger, Jens
Pelzer, Georg
Horn, Florian
Erber, Ramona
Wunderle, Marius
Emons, Julius
Nabieva, Naiba
Fuhrich, Nicole
Michel, Thilo
Hartmann, Arndt
Fasching, Peter A.
Anton, Gisela
- DOI
-
10.1002/mp.14043
- URN
-
urn:nbn:de:bvb:29-opus4-153504
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:45 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rauch, Thomas
- Rieger, Jens
- Pelzer, Georg
- Horn, Florian
- Erber, Ramona
- Wunderle, Marius
- Emons, Julius
- Nabieva, Naiba
- Fuhrich, Nicole
- Michel, Thilo
- Hartmann, Arndt
- Fasching, Peter A.
- Anton, Gisela
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2020
Ähnliche Objekte (12)
Invasive Breast Cancer: Recognition of Molecular Subtypes
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
Mammographic texture as new and independent breast cancer risk factor
Untersuchung der Invasivität von primären Endometriosezellen
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Invasive Breast Cancer: Recognition of Molecular Subtypes
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
Mammographic texture as new and independent breast cancer risk factor
Untersuchung der Invasivität von primären Endometriosezellen
Teilnahmerate an einer chemopräventiven Behandlung in der IBIS-II-Studie : eine prospektive Kohortenstudie im Rahmen des Mammographiescreenings
Invasive Breast Cancer: Recognition of Molecular Subtypes
Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
Endocrine Treatment for Breast Cancer Patients Revisited—History, Standard of Care, and Possibilities of Improvement
CDK4/6 Inhibitors—Overcoming Endocrine Resistance Is the Standard in Patients with Hormone Receptor-Positive Breast Cancer
Promoting-Activity-Test : mitogene Wirkung von Xenobiotika als Indikator ihrer tumorigenen Potenz in einem In-vivo-Kurzzeittestsystem
Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
Quality Assured Health Care in Certified Breast Centers and Improvement of the Prognosis of Breast Cancer Patients
Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening
Mammographic texture as new and independent breast cancer risk factor
Untersuchung der Invasivität von primären Endometriosezellen